Haloperidol Solution
FDA Label NDC 0121-0581

44 label sections · Submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma for the product Haloperidol (NDC 0121-0581). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, increased mortality in elderly patients with dementia-related psychosis, clinical pharmacology, indications and usage, contraindications, adults, children, tardive dyskinesia, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.